Sponsor pipeline

Lupin Ltd. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 3

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06523400	The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy…	Myotonic Dystrophy	Recruiting	2026-09-24
NCT07097701	An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of…	Myotonia	Recruiting	2025-12-22
NCT06549400	An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily…	Myotonic Dystrophy	Enrolling by Invitation	2026-01-26
Not specified
NCT07154654	Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic…	Myotonic Disorders	Recruiting	2025-09-23
NCT07732439	An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking…	Myotonic Dystrophy 1	Not Yet Recruiting	2026-07-28

Get alerts when Lupin Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.